Magdalena Chechlińska

Author

The Maria Sklodowska-Curie National Research Institute of Oncology ORCID

Also Known As

A. Ayhan, Jolanta Kupryjanczyk, M Chechlinska, M Chechlińska, M. Chechlinska, Magdalena Chechlinska, Magdalena Chechlińska, Magdelena Chechlinska

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Newcastle University Postgraduate School of Molecular Medicine Oxford University Hospitals NHS Trust

About

Magdalena Chechlińska is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	420
2	Cell Biology	2	2	153
3	Engineering	1	1	10
4	Natural Sciences	1	1	79
5	Public Health	1	1	14

Magdalena Chechlińska

Publications

810

Citations

H-Index

Page 1

	Year	Citations
Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis Janina Kamińska, M Kowalska, Beata Kotowicz, Oncology	2006	119
Clinical Significance of Serum Cytokine Measurements in Untreated Colorectal Cancer Patients: Soluble Tumor Necrosis Factor Receptor Type I &ndash; An Independent Prognostic Factor Janina Kamińska, Marek P. Nowacki, M Kowalska, Tumor Biology	2005	107
Critical Involvement of the ATM-Dependent DNA Damage Response in the Apoptotic Demise of HIV-1-Elicited Syncytia Jean‐Luc Perfettini, Roberta Nardacci, Mehdi Bourouba, PLoS ONE Critical InvolvementImmunologyMolecular BiologyCell DeathWild Type Hiv-1	2008	79
Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection Maria Sromek, Maciej Głogowski, Magdalena Chechlińska, Cellular Oncology Lung InflammationMedicinePathologyMir-486 LevelsBronchial Neoplasm	2017	74
A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration Grzegorz Rymkiewicz, Beata Grygalewicz, Magdalena Chechlińska, Modern Pathology Lymphoid NeoplasiaMedicineHematologyHistopathologyPathology	2018	66
The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes Magdalena Kowalewska, Magdalena Chechlińska, Sergiusz Markowicz, European Journal of Cancer Lymphoid NeoplasiaOncologyMedicineImmunologyPathology	2006	54
microRNAs in uterine sarcomas and mixed epithelial–mesenchymal uterine tumors: a preliminary report Magdalena Kowalewska, Elwira Bakuła‐Zalewska, Magdalena Chechlińska, Tumor Biology Uterine SarcomasTumor BiologyTumoral PathologyUterine FibroidsMalignant Disease	2013	31
Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas Michalina Zajdel, Grzegorz Rymkiewicz, Maria Sromek, Cancers	2019	24
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications Joanna Przybył, Katarzyna Kozak, Sławomir Falkowski, Medical Oncology	2014	21
miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B–cell lymphoma Michalina Zajdel, Grzegorz Rymkiewicz, Magdalena Chechlińska, Tumor Biology	2015	20

Page 1